TEVA FY 2019 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$36B

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$16.9B-10.4% YoY

Gross Profit

$7.5B44.6% margin

Operating Income

-$443M-2.6% margin

Net Income

-$999M-5.9% margin

EPS (Diluted)

$-0.92

Cash Flow

Operating Cash Flow

$538M

Free Cash Flow

$419M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$57.5B

Total Liabilities

$42.4B

Stockholders' Equity

$14.0B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16.9B	$18.9B	-10.4%
Gross Profit	$7.5B	$8.3B	-9.2%
Operating Income	-$443M	-$1.6B	+72.9%
Net Income	-$999M	-$2.1B	+53.5%